We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

206 hedge funds and large institutions have $5.22B invested in Legend Biotech in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more call options, than puts

Call options by funds: $58.4M | Put options by funds: $19.4M

60% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 58

26% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 27

3% more funds holding

Funds holding: 200 → 206 (+6)

0.22% more ownership

Funds ownership: 26.05% → 26.27% (+0.22%)

10% less capital invested

Capital invested by funds: $5.78B → $5.22B (-$559M)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
206
Holders Change
+6
Holders Change %
+3%
% of All Funds
3%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
34
Increased
93
Reduced
58
Closed
27
Calls
$58.4M
Puts
$19.4M
Net Calls
+$39M
Net Calls Change
+$40.4M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$70.6M
2
Morgan Stanley
Morgan Stanley
New York
+$62.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$61M
4
BlackRock
BlackRock
New York
+$40.9M
5
Millennium Management
Millennium Management
New York
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$197M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$69.3M
3
NIP
Nicholas Investment Partners
California
-$35.9M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.8M
5
HA
HHLR Advisors
Cayman Islands
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$770M -$197M -3,107,454 -20%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$650M +$70.6M +1,114,848 +12%
RCM
3
RA Capital Management
Massachusetts
$377M – – –
HA
4
HHLR Advisors
Cayman Islands
$360M -$28.6M -451,983 -7%
BlackRock
5
BlackRock
New York
$317M +$40.9M +645,154 +14%
Capital World Investors
6
Capital World Investors
California
$144M -$119K -1,872 -0.1%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$139M +$61M +962,381 +72%
Massachusetts Financial Services
8
Massachusetts Financial Services
Massachusetts
$119M +$7.46M +117,794 +6%
PBA
9
Paradigm Biocapital Advisors
New York
$114M -$8.29M -130,836 -6%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$112M +$8.33M +131,379 +8%
Capital International Investors
11
Capital International Investors
California
$110M -$514K -8,116 -0.4%
Morgan Stanley
12
Morgan Stanley
New York
$107M +$62.3M +983,329 +123%
Westfield Capital Management
13
Westfield Capital Management
Massachusetts
$107M +$6.85M +108,097 +6%
Holocene Advisors
14
Holocene Advisors
New York
$106M +$31.1M +491,433 +39%
Federated Hermes
15
Federated Hermes
Pennsylvania
$104M -$2.44M -38,524 -2%
PCH
16
Polar Capital Holdings
United Kingdom
$82.5M -$31.8M -501,642 -27%
AllianceBernstein
17
AllianceBernstein
Tennessee
$71.4M +$5.33M +84,076 +8%
TCM
18
TimesSquare Capital Management
New York
$64.1M +$9.01M +142,118 +15%
ACH
19
ArrowMark Colorado Holdings
Colorado
$64.1M -$617K -9,729 -0.9%
State Street
20
State Street
Massachusetts
$62.4M +$10.8M +171,159 +20%
JJ
21
Johnson & Johnson
New Jersey
$49M – – –
MICM
22
Matthews International Capital Management
California
$48.7M -$19.9M -314,254 -28%
APM
23
Avidity Partners Management
Texas
$41.2M -$17.9M -282,000 -29%
PHS
24
PFM Health Sciences
California
$40.9M – – –
Adage Capital Partners
25
Adage Capital Partners
Massachusetts
$37M -$69.3M -1,093,510 -64%
1
2 3 4 5

LEGN Hedge Fund Activity: Q4 2023 in Review

206 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2023, worth a combined $5.22B — down 9.7% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new LEGN positions and 27 closed out — a net gain of 7 holders — while 93 added to existing stakes and 58 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $197M.

  • 206 institutional investors held Legend Biotech (LEGN) as of Q4 2023, up from 200 in Q3 2023.
  • Funds reported $5.22B of Legend Biotech stock for Q4 2023, down 9.7% quarter-over-quarter.
  • 34 funds opened new Legend Biotech positions in Q4 2023 and 27 closed out, a net change of +7 holders.
  • The largest Legend Biotech buyer in Q4 2023 was T. Rowe Price Associates, an estimated $70.6M added.
  • The largest Legend Biotech seller in Q4 2023 was Fidelity Investments, an estimated $197M sold.

Based on aggregated 13F filings for Q4 2023.